240 related articles for article (PubMed ID: 12678409)
21. [Sensitivity to beta-lactam and aminoglycoside antibiotics of clinical Proteus strains as dependent upon on their species classification and the source of their isolation].
Shvidenko IG
Antibiot Med Biotekhnol; 1987 Nov; 32(11):850-5. PubMed ID: 3326520
[TBL] [Abstract][Full Text] [Related]
22. Natural antibiotic susceptibility of Klebsiella pneumoniae, K. oxytoca, K. planticola, K. ornithinolytica and K. terrigena strains.
Stock I; Wiedemann B
J Med Microbiol; 2001 May; 50(5):396-406. PubMed ID: 11339246
[TBL] [Abstract][Full Text] [Related]
23. [Enzymatic resistance to beta lactam antibiotics within the genus Proteus and evaluation of Proteus mirabilis phenotypes and genotypes for resistance to third- and fourth-generation cephalosporins].
Rodríguez C; Radice M; Perazzi B; Castro S; Juárez J; Santini P; Vay C; Famiglietti A; Gutkind G
Enferm Infecc Microbiol Clin; 2005 Mar; 23(3):122-6. PubMed ID: 15757582
[TBL] [Abstract][Full Text] [Related]
24. Natural antibiotic susceptibility of Salmonella enterica strains.
Stock I; Wiedemann B
Int J Antimicrob Agents; 2000 Nov; 16(3):211-7. PubMed ID: 11091038
[TBL] [Abstract][Full Text] [Related]
25. Natural antibiotic susceptibility of recently established coryneform bacteria.
Troxler R; Funke G; Von Graevenitz A; Stock I
Eur J Clin Microbiol Infect Dis; 2001 May; 20(5):315-23. PubMed ID: 11453591
[TBL] [Abstract][Full Text] [Related]
26. Identification and natural antibiotic susceptibility of Morganella morganii.
Stock I; Wiedemann B
Diagn Microbiol Infect Dis; 1998 Mar; 30(3):153-65. PubMed ID: 9572021
[TBL] [Abstract][Full Text] [Related]
27. [Proteus penneri].
Cantón R; Sánchez-Moreno MP; Morosini Reilly MI
Enferm Infecc Microbiol Clin; 2006 Oct; 24 Suppl 1():8-13. PubMed ID: 17125662
[TBL] [Abstract][Full Text] [Related]
28. [Prevalence of Proteus mirabilis strains in clinical specimens and evaluation of their resistance to selected antibiotics].
Sekowska A; Janicka G; Wróblewska J; Kruszyńska E
Pol Merkur Lekarski; 2004 Nov; 17(101):538-40. PubMed ID: 15754653
[TBL] [Abstract][Full Text] [Related]
29. In vitro activities of antimicrobial agents against Proteus species from clinical specimens.
Na'was TE; Mawajdeh S; Dababneh A; al-Omari A
Br J Biomed Sci; 1994 Jun; 51(2):95-9. PubMed ID: 8049615
[TBL] [Abstract][Full Text] [Related]
30. [Antibiotic sensitivity of forty-four strains of group EF4 bacteria: study of minimum inhibitory concentrations using the agar dilution method].
Lion C; de Monchy P; Weber M; Conroy MC; Mory F; Burdin JC
Pathol Biol (Paris); 1992 May; 40(5):471-8. PubMed ID: 1495829
[TBL] [Abstract][Full Text] [Related]
31. [The incidence of extended spectrum beta-lactamases in Proteus mirabilis strains isolated in 2007-2009].
Kwiecińska-Piróg J; Bogiel T; Gospodarek E
Przegl Epidemiol; 2010; 64(3):395-8. PubMed ID: 20976952
[TBL] [Abstract][Full Text] [Related]
32. In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics.
Alhambra A; Cuadros JA; Cacho J; Gómez-Garcés JL; Alós JI
J Antimicrob Chemother; 2004 Jun; 53(6):1090-4. PubMed ID: 15117925
[TBL] [Abstract][Full Text] [Related]
33. [The susceptibility of Proteus mirabilis strains isolated from white stork (Ciconia ciconia)].
Kwiecińska-Piróg J; Bogiel T; Gospodarek E; Kasprzak M; Jerzak L; Kamiński P
Med Dosw Mikrobiol; 2011; 63(2):139-44. PubMed ID: 22184908
[TBL] [Abstract][Full Text] [Related]
34. [Dynamics of drug resistance in Proteus mirabilis cultures 1970-1985].
Shvidenko IG
Antibiot Khimioter; 1988 Apr; 33(4):294-7. PubMed ID: 3291802
[TBL] [Abstract][Full Text] [Related]
35. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P
J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
[TBL] [Abstract][Full Text] [Related]
36. Resistance to beta-lactam antibiotics Proteus strains.
Lachmajer-Lutoslawska M; Bobrowski M
Acta Microbiol Pol A; 1975; 8(3):141-9. PubMed ID: 1103580
[TBL] [Abstract][Full Text] [Related]
37. Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection.
Mutnick AH; Turner PJ; Jones RN
J Chemother; 2002 Jun; 14(3):253-8. PubMed ID: 12120879
[TBL] [Abstract][Full Text] [Related]
38. Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases.
Endimiani A; Luzzaro F; Brigante G; Perilli M; Lombardi G; Amicosante G; Rossolini GM; Toniolo A
Antimicrob Agents Chemother; 2005 Jul; 49(7):2598-605. PubMed ID: 15980325
[TBL] [Abstract][Full Text] [Related]
39. Integrons, β-lactamase and qnr genes in multidrug resistant clinical isolates of Proteus mirabilis and P. vulgaris.
Mokracka J; Gruszczyńska B; Kaznowski A
APMIS; 2012 Dec; 120(12):950-8. PubMed ID: 23030307
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains.
Tomaso H; Al Dahouk S; Hofer E; Splettstoesser WD; Treu TM; Dierich MP; Neubauer H
Int J Antimicrob Agents; 2005 Oct; 26(4):279-84. PubMed ID: 16143497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
